Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Aripiprazole”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT06236451
What this trial is testing

Atypical Antipsychotic-induced Mitochondrial Dysfunction in Patients With Schizophrenia

Who this might be right for
Schizophrenia
All India Institute of Medical Sciences, Bhubaneswar 60
Large-scale testing (Phase 3)Ended earlyNCT01122927
What this trial is testing

Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.

Who this might be right for
Adolescent SchizophreniaChild or Adolescent Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Otsuka Pharmaceutical Development & Commercialization, Inc. 524
Testing effectiveness (Phase 2)Study completedNCT00420459
What this trial is testing

A Prospective Open-label Study of Aripiprazole in Fragile X Syndrome

Who this might be right for
Fragile X Syndrome
Indiana University 12
Not applicableStudy completedNCT01739127
What this trial is testing

Comparison of Aripiprazole Versus Higher Metabolic Risk Antipsychotic Drugs on Adiposity Using MRI

Who this might be right for
Psychotic DisordersBipolar DisorderMetabolic Syndrome X
University of British Columbia 83
Large-scale testing (Phase 3)Study completedNCT01795547
What this trial is testing

Aripiprazole Once-monthly Versus Paliperidone Palmitate in Adult Patients With Schizophrenia

Who this might be right for
Schizophrenia
H. Lundbeck A/S 295
Post-approval studies (Phase 4)Study completedNCT00484471
What this trial is testing

ABLE: Abilify in Bipolar Disorder for Long-term Effectiveness

Who this might be right for
Bipolar Disorder
Korea Otsuka International Asia Arab 127
Testing effectiveness (Phase 2)Study completedNCT02722967
What this trial is testing

Exploratory Trial to Assess the Functionality of an Integrated Call Center for the Digital Medicine System

Who this might be right for
SchizophreniaMajor Depressive DisorderBipolar I Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 49
Post-approval studies (Phase 4)Study completedNCT00232687
What this trial is testing

A Switch Study of BMS-337039 in Schizophrenic Out-patients

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 450
Post-approval studies (Phase 4)Study completedNCT01026584
What this trial is testing

Efficacy and Safety of Aripiprazole in First Episode Psychosis

Who this might be right for
First Episode Psychosis
Chonbuk National University Hospital 55
Post-approval studies (Phase 4)Study completedNCT00181779
What this trial is testing

Aripiprazole for the Treatment of Mania in Children and Adolescents With Bipolar Disorder

Who this might be right for
Bipolar DisorderMania
Massachusetts General Hospital 20
Not applicableStudy completedNCT03386851
What this trial is testing

Abilify Maintena PMS in Schizophrenia Patients or Bipolar 1 Disorder

Who this might be right for
SchizophreniaBipolar 1 Disorder
Korea Otsuka Pharmaceutical Co., Ltd. 1,030
Post-approval studies (Phase 4)UnknownNCT00541554
What this trial is testing

Reversal of Antipsychotic-Induced Hyperprolactinemia, Weight Gain, Hyperglycemia and Dyslipidemia

Who this might be right for
HyperprolactinemiaWeight GainDyslipidemia
Genovate Biotechnology Co., Ltd.,
Large-scale testing (Phase 3)Study completedNCT00110461
What this trial is testing

Aripiprazole in Children and Adolescents With Bipolar I Disorder

Who this might be right for
Bipolar Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 296
Post-approval studies (Phase 4)Study completedNCT01085383
What this trial is testing

Aripiprazole and Prolactin Study

Who this might be right for
Hyperprolactinemia
University of Oxford 15
Not applicableUnknownNCT04907279
What this trial is testing

Aripiprazole Once-Monthly in Hospitalized Patients (INITIATE)

Who this might be right for
SchizophreniaSchizo Affective DisorderBipolar I Disorder
Otsuka Canada Pharmaceutical Inc. 200
Large-scale testing (Phase 3)Study completedNCT00036361
What this trial is testing

Broad Effectiveness: Study With Aripiprazole

Who this might be right for
SchizophreniaSchizoaffective Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 444
Early research (Phase 1)Study completedNCT02634463
What this trial is testing

Whole Blood and Plasma Sample Collection for the Development of Antipsychotic Immunoassays From Participants Taking Aripiprazole, Olanzapine, Paliperidone, or Risperidone

Who this might be right for
ImmunoassayAntipsychotic
Janssen Research & Development, LLC 81
Post-approval studies (Phase 4)UnknownNCT01710163
What this trial is testing

Potentiation of Quetiapine Treatment With Lithium or Aripiprazole in Bipolar 1 Nonresponders Patients

Who this might be right for
Bipolar I Disorder
University of Sao Paulo 50
Large-scale testing (Phase 3)Study completedNCT00665366
What this trial is testing

Study to Evaluate the Efficacy and Safety of Aripiprazole Administered With Lithium or Valproate Over 12 Weeks in the Treatment of Mania in Bipolar I Disorder

Who this might be right for
Bipolar Disorder Mania
Otsuka Pharmaceutical Development & Commercialization, Inc. 493
Post-approval studies (Phase 4)Study completedNCT02949752
What this trial is testing

Aripiprazole as an Adjunct to Atypical Antipsychotics for Weight Reduction and Improvement in Metabolic Profile

Who this might be right for
Antipsychotics Weight Gain
Institute of Mental Health, Singapore 67
Next Page